Sri Sri Tattva Pavanahara Churna

 195 people have bought this recently
60 gm Churna in 1 Bottle
₹ 91 ₹130 30% OFF Save: ₹39
60 GM CHURNA 1 Bottle ₹ 91 ₹130 30% OFF Save: ₹39

  • Seller: Sriveda Sattva Pvt Ltd
    • Free Shipping Available
       

    Frequently Bought Together

    Frequently Bought Together



    Sri Sri Tattva Pavanahara Churna Information

    Sri Sri Tattva Pavanahara Churna is an ayurvedic medicine that is primarily used for the treatment of Acidity, Indigestion, Digestive Disorders. Secondary and off-label uses of Sri Sri Tattva Pavanahara Churna have also been mentioned below. The key ingredients of Sri Sri Tattva Pavanahara Churna are Haritaki, Hing. The properties of which have been shared below. The correct dosage of Sri Sri Tattva Pavanahara Churna depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.

    Ingredients of Sri Sri Tattva Pavanahara Churna

    Haritaki
    • Drugs which aid in swelling reduction following an injury
    • Drugs employed for the treatment of stomach ulcers.
    • Agents that lead to constriction of blood vessels causing reduction of blood flow to the site.
    • Agents that improve digestion and aid in food absorption.
    • Agents that eases the passage of stools and promotes bowel movement, used for the treatment of constipation.
    • Drugs used inducinng defaecation and bowl emptying in case of constipation.
    • Drugs which kill bacteria or inhibit their activities.
    Hing
    • Drugs used to treated muscle spasm and pain
    • A substance that eliminates excess gas from the stomach and intestines.

    Sri Sri Tattva Pavanahara Churna Benefits

    Sri Sri Tattva Pavanahara Churna is used to treat the following -

    Other Benefits

    • Flatulence


    Sri Sri Tattva Pavanahara Churna Side Effects

    No side effects of Sri Sri Tattva Pavanahara Churna have been reported in the medical literature. However, you should always consult your doctor before using Sri Sri Tattva Pavanahara Churna.



    Sri Sri Tattva Pavanahara Churna Related Warnings

    • Is the use of Sri Sri Tattva Pavanahara Churna safe for pregnant women?


      Sri Sri Tattva Pavanahara Churna is safe to take during pregnancy.

      Safe
    • Is the use of Sri Sri Tattva Pavanahara Churna safe during breastfeeding?


      Sri Sri Tattva Pavanahara Churna is safe for breastfeeding women.

      Safe
    • What is the effect of Sri Sri Tattva Pavanahara Churna on the stomach?


      Sri Sri Tattva Pavanahara Churna is considered safe for the stomach.

      Safe
    • Is the use of Sri Sri Tattva Pavanahara Churna safe for children?


      Sri Sri Tattva Pavanahara Churna is not safe for paediatric use.

      Not Used By Children
    • Can I take Sri Sri Tattva Pavanahara Churna with alcohol?


      No research has been done on this till date. Therefore, it is not known what the effect of taking Sri Sri Tattva Pavanahara Churna with alcohol will be.

      Unknown
    • Does Sri Sri Tattva Pavanahara Churna cause drowsiness?


      It is safe to drive or work after taking Sri Sri Tattva Pavanahara Churna as it does not make you drowsy.

      No
    • Is this Sri Sri Tattva Pavanahara Churna habit forming or addictive?


      Chances of addiction to Sri Sri Tattva Pavanahara Churna are nil

      No

    This medicine data has been created by -

    Dr. Braj Bhushan Ojha

    BAMS, Gastroenterology, Dermatology, Psychiatry, Ayurveda, Sexology, Diabetology
    10 Years of Experience


    References

    Ministry of Health and Family Welfare. Department of Ayush: Government of India. [link]. Volume 1. Ghaziabad, India: Pharmacopoeia Commission for Indian Medicine & Homoeopathy; 1986: Page No 62-63

    Ministry of Health and Family Welfare. Department of Ayush: Government of India. [link]. Volume 1. Ghaziabad, India: Pharmacopoeia Commission for Indian Medicine & Homoeopathy; 1986: Page No 64-66

    C.K. Kokate ,A.P. Purohit, S.B. Gokhale. [link]. Forty Seventh Edition. Pune, India: Nirali Prakashan; 2012: Page No 1.116-1.117